
---
nice.evidencecategory: 
---

### Evidence Statement CG66ES263
The study341 calculated the prevalence of a GFR <60 ml/min 1.73 m2 and normoalbuminuria
after excluding 23 of 43 patients whose normoalbuminuric status was possibly altered by the
use of RAS inhibitors. After this adjustment the prevalence of a <60 ml/min 1.73 m2 and
normoalbuminuria was 20 of 86 (23%). Level 2+

[@MacIsaac_2004]

